INVESTOR RELATIONS

CORPORATE OVERVIEW

Immunome is a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease.

LATEST NEWS

LATEST PRESENTATION

11/15/2022

Immunome Corporate Presentation

corporate deck

LATEST EVENTS

09/29/2021 08:40 AM ET

Cantor Global Healthcare Conference

09/29/2021 08:40 AM ET

Cantor Global Healthcare Conference

Menu